Using clinical features and circulating tumor DNA markers (MYC mutations, MYC-immunoglobulin translocations and Epstein-Barr virus fragmentomics), we trained six penalized logistic regression models with tenfold crossvalidation (n = 212). Here, MYC is linked to neoplasm.